We report the identification of an additional member of the glial cell line-derived neurotrophic factor (GDNF) family receptor, termed GFR␣3, that is homologous to the previously identified GDNF and neurturin ligand binding receptors GFR␣1 and GFR␣2. GFR␣3 is 32% and 37% identical to GFR␣1 and GFR␣2, respectively. RNase protection assays show that whereas gfr␣1 and gfr␣2 are abundant in both developing and adult brain, gfr␣3 is exclusively expressed during development. All receptors are widely present in both the developing and adult peripheral nervous system and in peripheral organs. For instance, in situ hybridization shows that the developing liver, stomach, intestine, kidney, and sympathetic chain, which all contain retexpressing cells, transcribe unique complementary and overlapping patterns of most or all of the GDNF family receptors and ligands. In sensory neurons of the trigeminal ganglion gfr␣2 and gfr␣3 are expressed in different subpopulations of neurons, whereas gfr␣1 is coexpressed in some gfr␣2 and gfr␣3-positive neurons. We find that the gfr␣1 population of trigeminal neurons is absent in GDNF null mutant mice, suggesting that GDNF signals in vivo by interacting with GFR␣1. Thus, our results show that there are at least three members in the GDNF family of ligand binding receptors and that these receptors may be crucial in conferring ligand specificity in vivo. The unique complementary and overlapping expression of gfr␣3 implies distinct functions in the developing and adult mouse from that of GFR␣1 and GFR␣2.
In the vertebrate nervous system, the survival of many neuronal populations is controlled by neurotrophic factors often produced by the targets of innervation. A very wellcharacterized family of neurotrophic factors is the neurotrophin (NT) family, which includes nerve growth factor, brainderived neurotrophic factor, NT3, and NT4 (1) . These neurotrophic factors display a remarkable complementary and cooperative action during development of the peripheral and central nervous systems. Many of the different functional classes of dorsal root, trigeminal, vestibular, and auditory ganglion neurons depend for their survival on specific NTs (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) , and consistently different functional classes of neurons express different NT receptors (15, 16) . NT3 also has been suggested to play a role for somatic sensory neurons before the period of programmed cell death affecting survival and differentiation (13, 14, (17) (18) (19) (20) (21) , and many cultured neurons that initially require NT3 become dependent on another NT member at later developmental stages (22, 23) . More recently a developmental switch in NT dependency has been shown to occur also in vivo in NT gene-targeted null mutant mice (24) .
The switch from NT3 dependency is paralleled by the downregulation of the NT3 receptor, trkC (25) .
Recently, a family of neurotrophic factors has been discovered, including the structurally related ligands glial cell linederived neurotrophic factor (GDNF) and neurturin (NTN) (26, 27) . They are distant members to the transforming growth factor ␤ family. GDNF is a potent survival factor for several populations of central neurons in culture and in vivo. GDNF protects lesioned adult substantia nigra dopaminergic neurons from death (26, (28) (29) (30) and rescues developing and lesioned adult spinal cord motor neurons (31) (32) (33) (34) (35) . GDNF also promotes the survival and morphologic differentiation of cerebellar Purkinje cells and lesioned locus coeruleus noradrenergic neurons (36, 37) . In vitro, GDNF promotes the survival of dissociated chicken parasympathetic, sympathetic, visceral, and cutaneous sensory neurons (38, 39) and rat sensory and sympathetic neurons (40) . A neurotrophic role for GDNF in peripheral neurons recently has been directly demonstrated in GDNF null mutant mice (34, 35, 41) . GDNF also has been shown to be involved during the inductive epithelialmesenchymal interactions that accompany kidney organogenesis (34, 35, 41) . Less is known about the functions of NTN. In culture, this factor has been shown to stimulate the survival of peripheral sensory and sympathetic neurons (27) .
GDNF family ligands thus are secreted molecules that play fundamental roles during inductive events of organogenesis as well as for cell survival and differentiation in the nervous system. Last year components of the receptor system mediating the effects of GDNF and NTN were discovered. The glycosylphosphatidylinositol membrane-linked receptor subunit, GDNFR␣͞TrnR1, which will be referred to as GDNF family receptor ␣1 (GFR␣1), binds GDNF. The complex GDNF-GFR␣1 is required for subsequent Ret binding and activation (42) (43) (44) (45) .
Recently, a novel receptor TrnR2͞NTNR-a͞RETL1 (GFR␣2) displaying close to 50% amino acid homology to GFR␣1 was identified and characterized (39, (46) (47) (48) . GDNF and NTN can activate Ret (49) in cultured cell lines by interacting with either GFR␣1 or GFR␣2. However, when present at low concentrations GDNF and NTN can display a preference for GFR␣1 and GFR␣2, respectively (39, 47) .
We report the identification of a receptor called GFR␣3 based on homology to GFR␣1 and GFR␣2. GFR␣3 is 32% and 37% identical to GFR␣1 and GFR␣2, respectively. Our characterization of this receptor suggests that it play roles in peripheral tissues and in the nervous system that are distinct from those of GFR␣1 and GFR␣2.
MATERIALS AND METHODS

Gfr␣3
Cloning. GFR␣3 was identified by a BLAST search in the dbEST sequence databank by using the protein sequence of GFR␣1 as template (43) . Two mouse expressed sequence tags (ESTs) were significantly different from both GFR␣1 and GFR␣2 (mj11d08 and mj08d05). These two cDNAs were obtained through the American Type Culture Collection and subcloned in pBSKSϩ. A restriction enzyme map was established, and short pieces of the cDNAs were subcloned and subjected to DNA sequence analysis. The deduced amino acid sequence showed that the complete ORF of GFR␣3 was present in one of the EST clones. However, this clone lacked one nucleotide, causing a translational frame-shift at amino acid 69 in GFR␣3. Reverse transcriptase-PCR therefore was used to clone a 850-bp cDNA fragment spanning this region of GFR␣3 by using mouse whisker follicle and heart RNA as templates. Sequence analysis of such cDNA fragments revealed the presence of an additional nucleotide, a thymidine, at leucine 69 in GFR␣3 in all cDNAs sequenced, suggesting a point mutation in the ATCC cDNA clone.
Probes. The rat GFR␣1 and the mouse ret probes have been described previously (50) . The rat GDNF, the mouse GFR␣2, GFR␣3, and NTN cDNA probes corresponding to nucleotides 380-800 (26), 805-1215 (46), 601-910 (this paper), and 613-963 (27) , respectively, was prepared as follows. cDNAs were isolated by reverse transcriptase-PCR using total RNA as template. The first-strand synthesis was primed with oligo(dT) primers (Pharmacia, Uppsala) and avian myeloblastosis virus reverse transcriptase (Promega). The cDNA fragments then were amplified by PCR using Taq polymerase and primers within the reported mouse ORFs. In the case of NTN, the Expand Long Template PCR System (Boerhinger Mannheim) was used instead of Taq polymerase. The cDNAs were cloned into pBluescript and subjected to sequence analysis. All cRNA probes were synthesized from linearized plasmids as previously described (50) . The rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cRNA probe (51) used here as an internal control resulted in a 160-nt-long fragment.
RNase Protection Assay. Pregnant BALB͞c mice were killed by cervical dislocalization at different developmental time points, and the embryonic brains were dissected and frozen at Ϫ70°C until used. Adult BALB͞c mice were dissected, and different parts of the brain and peripheral organs were collected. Total RNA were extracted by using the LiClUrea procedure described by Auffray and Rougeon (52) . RNase protection assays were performed by using 10 g of total RNA as previously described (50) .
In Situ Hybridization Procedure. For in situ hybridization, tissues of time-staged embryos or postnatal mice were positioned on a metal block, frozen, and sectioned transversely (14 m) on a Leitz cryostat. All sections were thaw-mounted onto slides pretreated with 3-aminopropyl triethoxysilane (Sigma) and kept frozen until hybridization. Before use, the sections were fixed in 4% paraformaldehyde for 15 min and rinsed twice in PBS (pH 7.5) and twice in distilled water. A previously described protocol for nonradioactive digoxygenin UTPribonucleotide in situ hybridization then was used (www. cco.caltech.edu͞Ϸmercer͞htmls͞Big_in_situ.html).
The labeled neurons in the trigeminal ganglion were captured by using a 20ϫ objective on every eighth section (control mice n ϭ 6, gdnf Ϫ/Ϫ mice n ϭ 5), and the images were processed by using the IP-lab spectrum software (Signal Analytics, Vienna, VA). The signal-to-noise ratio of the in situ hybridization was very high (see figures), and the threshold for the identification of labeled cells therefore could be set high. The total number of trigeminal neurons and receptor expressing neurons were determined as previously described (13) .
Genotyping of GDNF Mutant Mice. Heterozygous GDNF mutant mice were bred, and their offspring were collected at birth and used for the experiments. All of the neonatal mice were genotyped for the wild-type and gdnf mutant alleles by PCR according to Pichel et al. (41) .
RESULTS
GFR␣3
Is a GDNF Family Receptor Homologue. GFR␣3 was identified by a BLAST search in the dbEST sequence databank by using the protein sequence of GFR␣1 as template (43, 44) . A large number of ESTs with partial but significant homology to GFR␣1 were identified. Aligning the sequences to GFR␣2 revealed that the majority of the cDNA clones encoded this receptor. Two mouse ESTs were significantly different from both GFR␣1 and GFR␣2 (mj11d08 and mj08d05). These two cDNAs were obtained through the American Type Culture Collection, subjected to restriction enzyme mapping, subcloned, and DNA-sequenced. The sequence analysis revealed that the two ESTs represented cDNAs of varying length encoding the same protein. One of the cDNAs was full length and contained a deduced protein of 397 amino acids (Fig. 1 , see Materials and Methods for details).
The sequence around the first ATG of GFR␣3 provided a strong context for initiation (53) with GCC in positions Ϫ3, Ϫ2, and Ϫ1 and a G in position ϩ1. Aligning GFR␣3 to GFR␣1 and GFR␣2 revealed 32% and 37% amino acid identity, respectively. Similar to GFR␣1 and GFR␣2, GFR␣3 contains a possible signal sequence, three potential Nglycosylation sites (amino acids 92-95, 145-148, and 306-309) and a putative glycosylphosphatidylinositol-linked hydrophobic C terminus. Furthermore, all 28 cysteins of GFR␣3 were conserved in GFR␣1 and GFR␣2. The result that GFR␣3 displays a lower homology to GFR␣1 and GFR␣2 than GFR␣1 and GFR␣2 does suggests that GFR␣3 is a more distant member in this family of receptors.
GFR␣3 Is Expressed Only During Early Stages of Neurogenesis in the Central Nervous System Whereas GDNF, NTN, and Their Receptors are Abundant Throughout Development. cDNA fragments of appropriate sizes to be transcribed and used as probes for RNase protection assays were generated for GDNF family ligands and receptors. All RNase protection assays were adjusted to the GAPDH internal control for equal loading. Although presented in arbitrary units the relative RNase protection assay of embryonic and adult total brain tissue revealed gfr␣3 transcripts as early as embryonic day (E)12 and E15. Expression of gfr␣3 was down-regulated to barely detectable levels by E18 and postnatal day (P) 1, and was below the detection limit at P3. The levels remained below the detection limit throughout the rest of postnatal life (Fig. 2) . In contrast to gfr␣3, gfr␣1 and gfr␣2 expression levels peaked around E15 after which they progressively declined to lower but significant adult levels (Fig. 2) .
GDNF Family Ligands and Receptors in the Adult Brain. The adult mouse brain was dissected and RNA prepared from 10 brain regions for the RNase protection assay. Whereas gfr␣1 and gfr␣2 transcripts were detected in all brain regions, gfr␣3 transcripts were not detectable (Fig. 3) . GDNF transcripts, like the abundant transcripts of gfr␣1 and gfr␣2, were present in most of the analyzed brain regions, and NTN transcripts were detected in all of them. Ret mRNA was abundant in the olfactory bulb, septum, thalamus, hypothalamus, colliculi, cerebellum, and brain stem.
GFR␣3 Is Widely Expressed in Developing and Adult Peripheral Organs. In the adult mouse, gfr␣3 messenger was detected in peripheral organs and ganglia. Its expression was remarkably closely linked to the one of ret (Fig. 4) . Trigeminal ganglion, pituitary gland, thymus, lung, and duodenum expressed gfr␣3 in proportions that resemble ret expression. Heart, kidney, muscle, and liver that contained no or low levels of ret also expressed little or no gfr␣3. Gfr␣1 and gfr␣2 were more widely expressed and were present in most peripheral organs. The only organ expressing one GDNF family receptor member was the spleen where exclusively gfr␣2 was present.
We used nonradioactive in situ hybridization to identify cells expressing GDNF family receptors and ligands in mouse embryonic tissues. At E13, GDNF and NTN were expressed in many organs such as the liver, mesenchyme of the kidney, mucosal epithelium of the intestine, stomach, and in the NTN, Fig. 5 ). Interestingly, gfr␣3 mRNA expression closely resembled that of GDNF and NTN being present in the mesenchyme of kidney, mucosal epithelium of the intestine, and sympathetic chain. In contrast, ret expression was localized to epithelial buds of the kidney and scattered cells in the smooth muscle layers of the intestine and stomach, which also often contained gfr␣1 mRNA (Fig. 5) . At E18 GDNF and NTN remained in the mucosal lining of the stomach and intestine, which at this stage also contained ret, and all GDNF family receptors (data not shown). NTN, GDNF, and all GDNF family receptors also were present in developing glomeruli of the kidney.
GFR␣1-3 Transcripts Are Individually or Jointly Expressed in Distinct Subpopulations of Trigeminal Ganglion
Neurons. Abundant levels of ret and gfr␣1-3 transcripts were detected in the adult trigeminal ganglion by RNase protection assay (Fig. 4) . By using in situ hybridization to identify the cells expressing gfr␣1-3 and ret in the trigeminal ganglion, all GDNF family receptors were clearly detected in neurons of the newborn (Fig. 6) and adult trigeminal ganglion. Already during the initial examination of the sections it was evident that the receptors were expressed in a remarkably specific pattern within the ganglion. Gfr␣1-expressing cells were scattered throughout the ganglion, whereas gfr␣2-positive cells were concentrated in the ventral and gfr␣3-positive cells in the dorsal aspect of the ganglion. Simultaneous detection of gfr␣2 and gfr␣3 transcription led to a pattern of labeled neurons resembling ret.
The total number of trigeminal ganglion neurons was counted in cresyl violet-stained sections, and the number of gfr␣1-3 and ret-labeled neurons was measured. The percentage of trigeminal ganglion neurons expressing each receptor was calculated. Gfr␣1 and gfr␣2 both were expressed in approximately 10% of the trigeminal ganglion neurons. Almost 20% of the neurons were positive for gfr␣3 mRNA expression (Fig. 6) . The complementary pattern of gfr␣1-3 expression and the results showing that as much as 37% of the trigeminal ganglion neurons express ret mRNA (Fig. 6 ) suggest that GDNF family receptors could be expressed in different subpopulations of ganglion neurons.
To investigate this possibility, we hybridized sections of the trigeminal ganglion with cocktails containing mixes of two riboprobes. There was an additive increase of labeled neurons when a mixture of gfr␣2͞gfr␣3 probes were used (33% of the neurons) compared with individual probe hybridization (12% and 18%, respectively), showing that these receptors are largely expressed in distinct subpopulations of trigeminal ganglion neurons. A significant increase in the number of labeled neurons also was seen when the gfr␣1͞gfr␣2 mixture of probes was used compared with single probes (Fig. 6 ), whereas only a small increase in the number of labeled neurons was seen in sections hybridized with the gfr␣1͞gfr␣3 mix of probes. Thus, many of the gfr␣1 cells also express gfr␣3 and GFR␣1 Is a GDNF Receptor in Vivo. GDNF and NTN receptor interactions have been studied previously in cell culture. We sought to determine whether GDNF has a preference for any of the GDNF family receptors in vivo, including the GFR␣3 receptor. We used for this experiment GDNF null mutant mice (gdnf Ϫ/Ϫ mice), asking whether the absence of GDNF in vivo affects neurons expressing a specific GDNF family receptor member. However, we first examined the extent of GDNF transcription in the trigeminal ganglion. In situ hybridization revealed that most neurons in the trigeminal ganglion of normal mice expressed GDNF transcripts at E16, E18 as well as at birth (Fig. 7) . When we next examined the expression of GDNF family receptors in the GDNF null mutant mice we found that gfr␣1-positive cells were markedly reduced in the trigeminal ganglion, whereas no change in the number of gfr␣2 or gfr␣3 expressing cells was observed (Fig.  7) . Quantification confirmed that the loss of gfr␣1-positive cells in the gdnf compared with gdnf Ϫ/Ϫ mice was significant. Thus, these results suggest that GFR␣1 is the preferred receptor for GDNF in vivo in the trigeminal ganglion.
DISCUSSION
We describe the identification and characterization of a GDNF family receptor homologue, termed GFR␣3. This receptor is 32% and 37% homologous to GFR␣1 and GFR␣2, respectively. The specificities of ligand interaction of the latter two have been established in vitro. In the absence of Ret, GFR␣1 binds only to GDNF whereas GFR␣2 binds only to NTN (46, 47) . In the presence of Ret GFR␣2 also can bind GDNF if it is present at sufficient concentrations (48) and sympathetic neurons expressing GFR␣2 survive in response to GDNF, although NTN rescues more neurons (39) . Furthermore, GFR␣2 distinguishes between NTN and GDNF by inducing Ret phosphorylation at lower concentrations of NTN than GDNF ligand in cultured fibroblasts. However, GFR␣1 mediates Ret phosphorylation at similar concentrations of GDNF and NTN (46) . Most of the above studies were performed either by measuring physical interactions in cell-free systems or by receptor binding and phosphorylation on cultured cell lines. Interestingly, when analyzed in a neuronal survival assay in vitro GFR␣1 and GFR␣2 display higher specificity toward low doses of GDNF and NTN, respectively, compared with studies on fibroblast cell lines (39) . Because the specificity of tyrosine kinase receptors sometimes have been shown to be different in vivo than under culture conditions (54) we sought to determine whether GFR␣2 and GFR␣3 mediate GDNF signaling in vivo in the trigeminal ganglion and used for this experiment GDNF null mutant mice (41) . Our results suggest that at the level of GDNF present in the trigeminal ganglion during normal development only GFR␣1 expressing neurons are affected. We also have found that NTN is expressed in developing trigeminal ganglion neurons (unpublished results). The absence of gfr␣1 cells therefore also suggests that NTN is unable to compensate for the loss of GDNF in the null mutant mice. We conclude that GDNF could be the preferred ligand for GFR␣1 in vivo and that GDNF family receptors may bestow higher specificity in vivo than under culture conditions. We found that NTN was expressed in the adult duodenum, kidney, and liver, but GDNF and gfr␣1 had been downregulated. The only GDNF family receptor present in all of these adult tissues was GFR␣2. Our findings therefore are consistent with previous results that have shown that NTN could be the preferred GFR␣2 ligand and, furthermore, suggest a role for NTN in these organs.
What is the ligand interacting with the GFR␣3 receptor? Our in vivo results suggest that it may not be GDNF in the developing trigeminal ganglion. Surprisingly, we found that most peripheral tissues express more than one GDNF family receptor member. Similar results also were obtained for a subpopulation of neurons in the trigeminal ganglion, which coexpressed GFR␣2 and GFR␣3 with GFR␣1. GDNF is active as a homodimer and is believed to interact with dimers of GDNF family receptors. The results showing that many tissues and cells express more than one GDNF family receptor therefore may not necessarily suggest that they depend on more than one GDNF family ligand. Instead, it also opens up the possibility that heterodimer combinations of GFR␣1, GFR␣2, and GFR␣3 generate new receptors with distinct functions and pharmacological binding profiles for GDNF and NTN. In such a case, the role of a GDNF family receptor could exclusively be to modulate ligand binding to other receptor members. However, because most gfr␣3-positive trigeminal ganglion neurons did not express gfr␣1 or gfr␣2, GFR␣3 may at least in some instances play a role independent from GFR␣1 and GFR␣2. Data recently reported (55) indicate the existence of a third member in the GDNF family of ligands, termed persephin, which could be a GFR␣3 receptor ligand.
Our results suggest that GDNF family receptors display ligand preference in vivo and that GFR␣3 is a receptor with distinct roles from GFR␣1 and GFR␣2. The NTs have been shown to often support different functional classes of peripheral neurons. They do so by interacting with their receptors, which are restrictedly expressed in functionally distinct populations of sensory neurons (15, 16) . The remarkable subpopulation-specific expression of gfr␣1, gfr␣2, and gfr␣3 in the trigeminal ganglion shows that these receptors could play similar roles for GDNF family ligands during nervous system development. 
